LEAP THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Leap Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2017 to Q2 2024.
  • Leap Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 39.1M shares, a 166% increase year-over-year.
  • Leap Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 20.4M shares, a 80.5% increase from 2022.
  • Leap Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 11.3M shares, a 86.8% decline from 2021.
  • Leap Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 85.8M shares, a 44.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 39.1M +24.4M +166% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 27M +14.1M +109% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 20.4M +9.12M +80.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 27M +15.7M +138% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 14.7M +3.39M +29.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 12.9M -100M -88.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 11.3M -74.5M -86.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 11.3M -66.9M -85.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 11.3M -65.1M -85.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 113M +36.9M +48.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 85.8M +26.5M +44.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 78.2M +1.9M +2.49% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 76.4M +23.9M +45.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 76.4M +44.7M +141% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 59.3M +36.7M +163% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 76.3M +52.4M +219% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-12
Q2 2020 52.4M +29.5M +129% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-13
Q1 2020 31.6M +12.4M +64.4% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-14
Q4 2019 22.6M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 23.9M +9.22M +62.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 22.9M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 19.2M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q3 2018 14.7M +5.31M +56.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q3 2017 9.4M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.